Conduit Pharmaceuticals (CDTTW) SEC Filings & 10K Form

→ Did Intel Just Dethrone Nvidia? (From Chaikin Analytics) (Ad)

Free CDTTW Stock Alerts

$0.07

0.00 (0.00%)

(As of 05/14/2024 ET)

Compare

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Recent Conduit Pharmaceuticals SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
05/02/2024 11:15 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form EFFECT
04/24/2024 4:00 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/24/2024 4:00 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/24/2024 4:00 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Tapolczay David (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
04/16/2024 4:27 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
04/16/2024 4:29 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
04/01/2024 3:30 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form NT 10-K
Get the Latest News and Ratings for CDTTW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
02/12/2024 11:51 AM	CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Polar Asset Management Partners Inc. (Filed by)	Form SC 13G/A
02/08/2024 12:15 PM	CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Saba Capital Management, L.P. (Filed by)	Form SC 13G/A
01/10/2024 3:43 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
12/18/2023 3:14 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 424B3
12/17/2023 11:15 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form EFFECT
12/14/2023 4:16 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Lewis-Hall Freda C (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Sragovicz Adam (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Tapolczay David (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) McNealey Jennifer Isacoff (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
12/05/2023 4:20 PM	Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
12/01/2023 3:50 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form S-1/A
12/01/2023 3:52 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
11/20/2023 7:37 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 10-Q/A
11/20/2023 4:29 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
10/17/2023 3:49 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form S-1 Registration statement under Securities Act of 1933
10/05/2023 4:25 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K/A
10/02/2023 3:30 PM	CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nirland Ltd (Filed by)	Form SC 13G
09/26/2023 4:37 PM	Algo Holdings, Inc. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Corvus Capital Ltd. (Reporting) Regan Andrew (Reporting)	Form 3 Initial statement of beneficial ownership of securities
09/26/2023 4:41 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Intelmed LLC (Reporting) Lewis-Hall Freda C (Reporting)	Form 3 Initial statement of beneficial ownership of securities
09/26/2023 4:42 PM	Bligh James (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)	Form 3 Initial statement of beneficial ownership of securities
09/26/2023 4:43 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) McNealey Jennifer Isacoff (Reporting)	Form 3 Initial statement of beneficial ownership of securities
09/26/2023 4:49 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Farley Chele Chiavacci (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/26/2023 4:30 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Heilbron Jack Kendrick (Reporting) Murphy Canyon Acquisition Sponsor, LLC (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
09/26/2023 4:34 PM	Charles Faith L. (Reporting) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer)	Form 3 Initial statement of beneficial ownership of securities
09/26/2023 4:34 PM	CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) CONDUIT PHARMACEUTICALS INC. (Issuer) Conduit Pharmaceuticals (Issuer) Tapolczay David (Reporting)	Form 3 Initial statement of beneficial ownership of securities
09/22/2023 3:32 PM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form CERT
09/22/2023 3:33 PM	CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) Conduit Pharmaceuticals (Subject) Nasdaq Stock Market LLC (Filed by)	Form 25-NSE
09/22/2023 8:25 AM	CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) CONDUIT PHARMACEUTICALS INC. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-A12B
09/13/2023 12:53 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
09/13/2023 12:56 PM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
09/13/2023 12:59 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 424B3
09/07/2023 3:31 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
Biden to Drop BOMBSHELL June 13th? (Ad) Biden’s days are numbered! According to a former CIA and Pentagon insider… He’s about to drop out of the presidential race on June 13th! Click here now to see his shocking evidence.
09/07/2023 3:31 PM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
08/31/2023 4:21 PM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
08/23/2023 3:30 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 424B3
08/23/2023 3:36 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/23/2023 3:39 PM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
08/16/2023 7:30 AM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/16/2023 7:31 AM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
08/14/2023 4:14 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
08/13/2023 11:15 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form EFFECT
07/21/2023 4:15 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/21/2023 4:15 PM	Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Murphy Canyon Acquisition Corp. (Subject) Conduit Pharmaceuticals (Subject)	Form 425
07/11/2023 3:35 PM	Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Murphy Canyon Acquisition Corp. (Filer) Conduit Pharmaceuticals (Filer)	Form S-4/A

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:CDTTW) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Conduit Pharmaceuticals (CDTTW) SEC Filings & 10K Form

Recent Conduit Pharmaceuticals SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info